spacer
home > ebr > autumn 2008 > tissue regeneration
PUBLICATIONS
European Biopharmaceutical Review

Tissue Regeneration

This article describes the potential for doctors to use platelet rich plasma in their daily practice in the aesthetic fields of mesotherapy, nappage and fillers.

A MULTIDISCIPLINARY PROGRAMME FOR SKIN REJUVENATION

From the centrifuged blood of the patient, we can obtain, in a specific tube, a plasma, with platelets and white cells separated from the red cells by a gel. Once we have this plasma, we can inject it into the patient’s skin in different ways: nappage mesotherapy and/or fillers. But before starting the protocol for aesthetics injections, we have to understand what autologous cell regeneration (ACR) means, and what the components of the PRP are.

WHAT IS AUTOLOGOUS CELL REGENERATION?

Autologous cell regeneration is the bio-stimulation of the cells of the dermis using an injection technique which utilises the patient’s own bio-active platelet rich plasma (PRP), including leucocytes. The aim of these injections is to stimulate and regenerate aged and damaged skin and hypodermal tissues, and to produce a new dermis.

WHAT IS PLATELET RICH PLASMA?

Platelet rich plasma is an autologous concentration of human platelets in a small volume of plasma measured as 1,000,000 platelets per mm3 or two to three times the native concentration of whole blood at a pH of 6.5-6.7 (whole blood pH is 7.0-7.2).

It is also referred to as autologous platelet gel, plasma rich growth factors (PRGFs) or autologous platelet concentrate. PRP is a concentration of the fundamental protein growth factors which have been proved to be actively secreted by platelets to initiate all wound healing.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Alain Gondinet graduated as a medical practitioner from Necker- Enfants Malades in 1975. In 1986 he founded the cosmetics company Bionuclea and invented Mesogel. He went on to co-found ARPHA, offering marketing and advertising services to the pharma industry. In 2002 he developed the concept of Antioxidative MesoTherapy with Dr André Dalloz-Bourguignon and became founding vice-president of the Association for the Development of Antioxidant Therapies. He works as a medical consultant for a number of companies worldwide and has contributed several articles to leading journals.
spacer
Dr Alain Gondinet
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

First-in-Human Workshop

7-8 May 2012, Berlin, Germany


More info >>

 
News and Press Releases

Kallik’s new approach to asset management delivers long term artwork automisation

Marketing and compliance departments can now have greater control over their assets –from logos and images to labelling copy – and a roadmap to automated artwork generation, thanks to Kallik’s online Asset Repository. It is the most cost-effective way to lay the foundation for future automisation of the artwork and labelling generation. The practice of centralising the content in a web-based asset library and reusing those assets across all marketing and trade communications is saving businesses thousands, if not millions, of pounds.
More info >>

 

 

Buy Atrovent Online no prescription Buy Symbicort Online no prescription Buy Flovent Online no prescription Buy Flonase Online no prescription Buy Rhinocort Online no prescription Buy Allegra Online no prescription Buy Advair Online no prescription Buy Combivent Online no prescription Buy Astelin Online no prescription Buy Spiriva Online no prescription Buy Ventolin Online no prescription
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement
.